Sandro Jube

1.2k total citations
14 papers, 927 citations indexed

About

Sandro Jube is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Clinical Biochemistry. According to data from OpenAlex, Sandro Jube has authored 14 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Clinical Biochemistry. Recurrent topics in Sandro Jube's work include Occupational and environmental lung diseases (7 papers), Advanced Glycation End Products research (4 papers) and S100 Proteins and Annexins (3 papers). Sandro Jube is often cited by papers focused on Occupational and environmental lung diseases (7 papers), Advanced Glycation End Products research (4 papers) and S100 Proteins and Annexins (3 papers). Sandro Jube collaborates with scholars based in United States, Italy and Türkiye. Sandro Jube's co-authors include Michele Carbone, Harvey I. Pass, Haining Yang, Giovanni Gaudino, Marco E. Bianchi, Zeyana S. Rivera, Dulal Borthakur, Pietro Bertino, Zeyana Rivera and Ian Pagano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Cancer Research.

In The Last Decade

Sandro Jube

14 papers receiving 910 citations

Peers

Sandro Jube
Pietro Bertino United States
Rhonda J. Staversky United States
Jonathan Goldberg United States
James D. Calore United States
N. V. Rao United States
Pietro Bertino United States
Sandro Jube
Citations per year, relative to Sandro Jube Sandro Jube (= 1×) peers Pietro Bertino

Countries citing papers authored by Sandro Jube

Since Specialization
Citations

This map shows the geographic impact of Sandro Jube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Jube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Jube more than expected).

Fields of papers citing papers by Sandro Jube

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandro Jube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Jube. The network helps show where Sandro Jube may publish in the future.

Co-authorship network of co-authors of Sandro Jube

This figure shows the co-authorship network connecting the top 25 collaborators of Sandro Jube. A scholar is included among the top collaborators of Sandro Jube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandro Jube. Sandro Jube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Pellegrini, Laura, Jiaming Xue, David Larson, et al.. (2017). HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma. Oncotarget. 8(14). 22649–22661. 42 indexed citations
2.
Wang, Lizhong, Runhua Liu, Peiying Ye, et al.. (2015). Intracellular CD24 disrupts the ARF–NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Nature Communications. 6(1). 5909–5909. 58 indexed citations
3.
Yang, Haining, Laura Pellegrini, Andrea Napolitano, et al.. (2015). Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death and Disease. 6(6). e1786–e1786. 58 indexed citations
4.
Fang, Qi, Sandro Jube, Andrea Napolitano, et al.. (2013). Continuous Exposure to Chrysotile Asbestos Can Cause Transformation of Human Mesothelial Cells via HMGB1 and TNF-α Signaling. American Journal Of Pathology. 183(5). 1654–1666. 76 indexed citations
5.
Jube, Sandro, Zeyana S. Rivera, Marco E. Bianchi, et al.. (2012). Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma. Cancer Research. 72(13). 3290–3301. 199 indexed citations
6.
Rivera, Zeyana, Soldano Ferrone, Xinhui Wang, et al.. (2012). CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma. Clinical Cancer Research. 18(19). 5352–5363. 76 indexed citations
7.
Carbone, Michele, Y. Izzettin Bariş, Pietro Bertino, et al.. (2011). Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proceedings of the National Academy of Sciences. 108(33). 13618–13623. 160 indexed citations
8.
Jube, Sandro, Zeyana Rivera, Giovanni Gaudino, et al.. (2011). Abstract 2600: HMGB1, a potential new target for mesothelioma therapy. Cancer Research. 71(8_Supplement). 2600–2600. 1 indexed citations
9.
Jube, Sandro & Dulal Borthakur. (2010). Transgenic Leucaena leucocephala expressing the Rhizobium gene pydA encoding a meta-cleavage dioxygenase shows reduced mimosine content. Plant Physiology and Biochemistry. 48(4). 273–278. 11 indexed citations
10.
Walton, Chad B., Sandro Jube, Paul Q. Patek, et al.. (2010). Ex vivo stimulation assay for T-cell responses for tuberculosis using LEAPS-peptide heteroconjugates. 3 indexed citations
11.
Yang, Haining, Zeyana Rivera, Sandro Jube, et al.. (2010). Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proceedings of the National Academy of Sciences. 107(28). 12611–12616. 200 indexed citations
13.
Jube, Sandro & Dulal Borthakur. (2008). Development of an Agrobacterium-mediated transformation protocol for the tree-legume Leucaena leucocephala using immature zygotic embryos. Plant Cell Tissue and Organ Culture (PCTOC). 96(3). 325–333. 19 indexed citations
14.
Jube, Sandro & Dulal Borthakur. (2007). Expression of bacterial genes in transgenic tobacco: methods, applications and future prospects. Electronic Journal of Biotechnology. 10(3). 0–0. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026